Protocol Ledger

NCT06512584 · Phase III · ACTIVE NOT RECRUITING

Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition

Interventional Phase III clinical trial protocol NCT06512584 sponsored by Chongqing Peg-Bio Biopharm Co in Gastroenterology, Hepatology, and Renal, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-09-03 Enrollment: 72 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06512584
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)72 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06512584
Protocol FieldVerified Registry Value
NCT IdentifierNCT06512584
Consolidated Lead SponsorChongqing Peg-Bio Biopharm Co
Therapeutic Condition CohortGastroenterology, Hepatology, and Renal
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment72 participants (ESTIMATED)
Registered Start Date2024-09-03
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Gastroenterology, Hepatology, and Renal Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI